Loyalhanna Therapeutics Inc.

Developing treatments for a group of diseases in dire need of safer therapies, brought along as medical foods, avoiding lengthy drug approval process.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Latrobe, PA, US
  • Currency USD
  • Founded January 2017
  • Employees 1
  • Incorporation Type C-corp

Company Summary

Developing treatments for a group of diseases in dire need of safer therapies. The first market is the crossover treatment group of Crohn's disease, psoriasis, rheumatoid arthritis, and ulcerative colitis. The treatment will be brought along as a medical food, and thus avoid the drug approval process.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free